Theranos Files Plan to CMS for Fixing California Lab Problems
This article is for subscribers only.
Theranos Inc. filed a plan to U.S. regulators to fix serious deficiencies at the company’s blood-testing lab in Newark, California, as founder Elizabeth Holmes works to regain credibility for her struggling startup.
The company submitted the proposed plan of correction late Friday to the Centers for Medicare and Medicaid Services, CMS spokesman Aaron Albright said in an e-mail.